These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2505183)

  • 61. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
    Ljunghall S; Larsson K; Lindh E; Lindqvist U; Rastad J; Akerström G; Wide L
    Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
    Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
    J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
    Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
    Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Peripheral metabolism of parathyroid hormone in patients with primary hyperparathyroidism as judged by immunological and biological studies.
    Gautvik KM; Gordeladze JO; Moxheim E; Gautvik VT
    Eur Surg Res; 1984; 16 Suppl 2():41-54. PubMed ID: 6723731
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.
    D'Amour P; Palardy J; Bahsali G; Mallette LE; DeLéan A; Lepage R
    J Clin Endocrinol Metab; 1992 Mar; 74(3):525-32. PubMed ID: 1740486
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
    Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.
    Malberti F; Surian M; Cosci P
    Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations.
    Hove K; Horst RL; Littledike ET; Beitz DC
    Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.
    Boucher A; D'Amour P; Hamel L; Fugère P; Gascon-Barré M; Lepage R; Ste-Marie LG
    J Clin Endocrinol Metab; 1989 Apr; 68(4):831-6. PubMed ID: 2921312
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multicenter clinical trial of 22-oxa-1,25-dihydroxyvitamin D3 for chronic dialysis patients.
    Yasuda M; Akiba T; Nihei H
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S108-11. PubMed ID: 12612965
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intravenous 1,25(OH)2 vitamin D3 therapy in haemodialysis patients: evaluation of direct and calcium-mediated short-term effects on serum parathyroid hormone concentration.
    Probst W; Fischer JA; Binswanger U
    Nephrol Dial Transplant; 1990; 5(6):457-60. PubMed ID: 2122324
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
    Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
    J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Malignancy hypercalcemia: evaluation of parathyroid function and response to treatment.
    Mallette LE; Beck P; Vandepol C
    Am J Med Sci; 1991 Oct; 302(4):205-10. PubMed ID: 1928231
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intraoperative parathyroid hormone concentration to confirm removal of hypersecretory parathyroid tissue and time to postoperative normocalcaemia in nine dogs with primary hyperparathyroidism.
    Graham KJ; Wilkinson M; Culvenor J; Dhand NK; Churcher RK
    Aust Vet J; 2012 Jun; 90(6):203-9. PubMed ID: 22632282
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Calcium-mediated parathyroid hormone release changes in patients treated with the calcimimetic agent cinacalcet.
    de Francisco AL; Izquierdo M; Cunningham J; Piñera C; Palomar R; Fresnedo GF; Amado JA; Unzueta MG; Arias M
    Nephrol Dial Transplant; 2008 Sep; 23(9):2895-901. PubMed ID: 18424820
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of calcitriol replacement on serum calcitonin and parathyroid hormone levels in CAPD patients.
    Quesada JM; Rodriguez M; Calderon de la Barca JM; Alvarez-Lara A; Martín-Malo A; Mateo A; Martinez ME; Aljama P
    Nephrol Dial Transplant; 1995; 10(1):70-4. PubMed ID: 7724033
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effect of cinacalcet on parathyroid hormone level in hypercalcemic hyperparathyroidism of patients with renal transplantation].
    Vaquero E; Esteban de la Rosa RJ; Oliva N; Fernández Castillo R; Fernández Gallegos R; Bravo Soto J
    Med Clin (Barc); 2012 Apr; 138(8):323-6. PubMed ID: 21492884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.